Sign Out
FC Tablet: Citicoline enhances effects of L-dihydroxyphenylalanine and levodopa.
It should not be synchronously used with drugs, which contain meclofenoxate.
Alcohol should not be consumed while the preparation usage.
Injection: Carbidopa, Levodopa and Entacapone: Citicoline may enhance the effects of levodopa, carbidopa and entacapone. The exact mechanism is unknown, but animal models suggest that Citicoline may increase dopamine levels in the brain and/or improve dopaminergic cell survival. In patients with Parkinson's disease, a few studies have demonstrated levodopa-saving effects, whereby the addition of Citicoline (500-1,200 mg/day) allowed for lower dosages of levodopa to be used with stable or improved therapeutic efficacy and reduced the side effects in some patients. However, data are limited.
Co-administration with Centrophenoxine: Must not be administered in conjunction with medications containing Centrophenoxine.
